当前位置: X-MOL 学术Cardiovasc. Drugs Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic
Cardiovascular Drugs and Therapy ( IF 3.4 ) Pub Date : 2021-07-30 , DOI: 10.1007/s10557-021-07217-8
Michele Correale 1 , Francesca Croella 2 , Alessandra Leopizzi 2 , Pietro Mazzeo 2 , Lucia Tricarico 2 , Adriana Mallardi 2 , Martino Fortunato 2 , Michele Magnesa 2 , Vincenzo Ceci 2 , Alessandra Puteo 1 , Massimo Iacoviello 2 , Matteo Di Biase 2 , Natale Daniele Brunetti 2
Affiliation  

COVID-19 pandemic has negatively impacted the management of patients with acute and chronic cardiovascular disease: acute coronary syndrome patients were often not timely reperfused, heart failure patients not adequately followed up and titrated, atrial arrhythmias not efficaciously treated and became chronic. New phenotypes of cardiovascular patients were more and more frequent during COVID-19 pandemic and are expected to be even more frequent in the next future in the new world shaped by the pandemic. We therefore aimed to briefly summarize the main changes in the phenotype of cardiovascular patients in the COVID-19 era, focusing on new clinical challenges and possible therapeutic options.



中文翻译:

COVID-19 大流行期间心血管疾病的演变表型

COVID-19 大流行对急性和慢性心血管疾病患者的管理产生了负面影响:急性冠状动脉综合征患者往往没有及时再灌注,心力衰竭患者没有得到充分的随访和滴定,房性心律失常没有得到有效治疗并转为慢性。在 COVID-19 大流行期间,心血管患者的新表型越来越频繁,预计在未来由大流行塑造的新世界中会更加频繁。因此,我们旨在简要总结 COVID-19 时代心血管患者表型的主要变化,重点关注新的临床挑战和可能的治疗选择。

更新日期:2021-07-30
down
wechat
bug